🟢 Solid Biosciences is trading 6% up in pre-market — no clear company-specific catalyst identified

Solid Biosciences is trading $6.27, up 5.91%, in pre-market; no clear company-specific announcement explaining the move was identified.

• The latest company release found was October 20, about research presentations at the upcoming ESGCT congress.
• October 26 biotech-rally coverage described Friday gains, without linking them to this pre-market move.
• Major indexes were modestly higher, below the 0.5% broad-market attribution threshold; premarket volume was unavailable.